Day Range5.080 - 5.270 | 52 Wk Range0.150 - 11.690 | Open / Close5.110 / 5.190 | Float / Outstanding9.384M / 9.467M |
Vol / Avg.17.368K / 137.924K | Mkt Cap49.134M | P/E- | 50d Avg. Price5.580 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float9.384M | EPS-0.960 |
TherapeuticsMD Stock (NASDAQ: TXMD) stock price, news, charts, stock research, profile.
Day Range5.080 - 5.270 | 52 Wk Range0.150 - 11.690 | Open / Close5.110 / 5.190 | Float / Outstanding9.384M / 9.467M |
Vol / Avg.17.368K / 137.924K | Mkt Cap49.134M | P/E- | 50d Avg. Price5.580 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float9.384M | EPS-0.960 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.570 | -2.750 | -2.1800 | ||||
REV | 26.800M | 20.917M | -5.883M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.
Other companies in TherapeuticsMD’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Lipocine (NASDAQ:LPCN) and Hepion Pharmaceuticals (NASDAQ:HEPA).
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on Wednesday, January 11, 2023. The analyst firm set a price target for 5.00 expecting TXMD to fall to within 12 months (a possible -3.66% downside). 5 analyst firms have reported ratings in the last year.
The stock price for TherapeuticsMD (NASDAQ: TXMD) is $5.19 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for TherapeuticsMD.
TherapeuticsMD’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for TherapeuticsMD.
TherapeuticsMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
TherapeuticsMD Stock (NASDAQ: TXMD) stock price, news, charts, stock research, profile.
Day Range5.080 - 5.270 | 52 Wk Range0.150 - 11.690 | Open / Close5.110 / 5.190 | Float / Outstanding9.384M / 9.467M |
Vol / Avg.17.368K / 137.924K | Mkt Cap49.134M | P/E- | 50d Avg. Price5.580 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float9.384M | EPS-0.960 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.570 | -2.750 | -2.1800 | ||||
REV | 26.800M | 20.917M | -5.883M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.
Other companies in TherapeuticsMD’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Lipocine (NASDAQ:LPCN) and Hepion Pharmaceuticals (NASDAQ:HEPA).
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on Wednesday, January 11, 2023. The analyst firm set a price target for 5.00 expecting TXMD to fall to within 12 months (a possible -3.66% downside). 5 analyst firms have reported ratings in the last year.
The stock price for TherapeuticsMD (NASDAQ: TXMD) is $5.19 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for TherapeuticsMD.
TherapeuticsMD’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for TherapeuticsMD.
TherapeuticsMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
TherapeuticsMD Stock (NASDAQ: TXMD) stock price, news, charts, stock research, profile.
Day Range5.080 - 5.270 | 52 Wk Range0.150 - 11.690 | Open / Close5.110 / 5.190 | Float / Outstanding9.384M / 9.467M |
Vol / Avg.17.368K / 137.924K | Mkt Cap49.134M | P/E- | 50d Avg. Price5.580 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float9.384M | EPS-0.960 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.570 | -2.750 | -2.1800 | ||||
REV | 26.800M | 20.917M | -5.883M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.
Other companies in TherapeuticsMD’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Lipocine (NASDAQ:LPCN) and Hepion Pharmaceuticals (NASDAQ:HEPA).
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on Wednesday, January 11, 2023. The analyst firm set a price target for 5.00 expecting TXMD to fall to within 12 months (a possible -3.66% downside). 5 analyst firms have reported ratings in the last year.
The stock price for TherapeuticsMD (NASDAQ: TXMD) is $5.19 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for TherapeuticsMD.
TherapeuticsMD’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for TherapeuticsMD.
TherapeuticsMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
TherapeuticsMD Stock (NASDAQ: TXMD) stock price, news, charts, stock research, profile.
Day Range5.080 - 5.270 | 52 Wk Range0.150 - 11.690 | Open / Close5.110 / 5.190 | Float / Outstanding9.384M / 9.467M |
Vol / Avg.17.368K / 137.924K | Mkt Cap49.134M | P/E- | 50d Avg. Price5.580 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float9.384M | EPS-0.960 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.570 | -2.750 | -2.1800 | ||||
REV | 26.800M | 20.917M | -5.883M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.
Other companies in TherapeuticsMD’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Lipocine (NASDAQ:LPCN) and Hepion Pharmaceuticals (NASDAQ:HEPA).
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on Wednesday, January 11, 2023. The analyst firm set a price target for 5.00 expecting TXMD to fall to within 12 months (a possible -3.66% downside). 5 analyst firms have reported ratings in the last year.
The stock price for TherapeuticsMD (NASDAQ: TXMD) is $5.19 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for TherapeuticsMD.
TherapeuticsMD’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for TherapeuticsMD.
TherapeuticsMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
TherapeuticsMD Stock (NASDAQ: TXMD) stock price, news, charts, stock research, profile.
Day Range5.080 - 5.270 | 52 Wk Range0.150 - 11.690 | Open / Close5.110 / 5.190 | Float / Outstanding9.384M / 9.467M |
Vol / Avg.17.368K / 137.924K | Mkt Cap49.134M | P/E- | 50d Avg. Price5.580 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float9.384M | EPS-0.960 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.570 | -2.750 | -2.1800 | ||||
REV | 26.800M | 20.917M | -5.883M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.
Other companies in TherapeuticsMD’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Lipocine (NASDAQ:LPCN) and Hepion Pharmaceuticals (NASDAQ:HEPA).
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on Wednesday, January 11, 2023. The analyst firm set a price target for 5.00 expecting TXMD to fall to within 12 months (a possible -3.66% downside). 5 analyst firms have reported ratings in the last year.
The stock price for TherapeuticsMD (NASDAQ: TXMD) is $5.19 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for TherapeuticsMD.
TherapeuticsMD’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for TherapeuticsMD.
TherapeuticsMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
TherapeuticsMD Stock (NASDAQ: TXMD) stock price, news, charts, stock research, profile.
Day Range5.080 - 5.270 | 52 Wk Range0.150 - 11.690 | Open / Close5.110 / 5.190 | Float / Outstanding9.384M / 9.467M |
Vol / Avg.17.368K / 137.924K | Mkt Cap49.134M | P/E- | 50d Avg. Price5.580 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float9.384M | EPS-0.960 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.570 | -2.750 | -2.1800 | ||||
REV | 26.800M | 20.917M | -5.883M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.
Other companies in TherapeuticsMD’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Lipocine (NASDAQ:LPCN) and Hepion Pharmaceuticals (NASDAQ:HEPA).
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on Wednesday, January 11, 2023. The analyst firm set a price target for 5.00 expecting TXMD to fall to within 12 months (a possible -3.66% downside). 5 analyst firms have reported ratings in the last year.
The stock price for TherapeuticsMD (NASDAQ: TXMD) is $5.19 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for TherapeuticsMD.
TherapeuticsMD’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for TherapeuticsMD.
TherapeuticsMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
TherapeuticsMD Stock (NASDAQ: TXMD) stock price, news, charts, stock research, profile.
Day Range5.080 - 5.270 | 52 Wk Range0.150 - 11.690 | Open / Close5.110 / 5.190 | Float / Outstanding9.384M / 9.467M |
Vol / Avg.17.368K / 137.924K | Mkt Cap49.134M | P/E- | 50d Avg. Price5.580 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float9.384M | EPS-0.960 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.570 | -2.750 | -2.1800 | ||||
REV | 26.800M | 20.917M | -5.883M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.
Other companies in TherapeuticsMD’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Lipocine (NASDAQ:LPCN) and Hepion Pharmaceuticals (NASDAQ:HEPA).
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on Wednesday, January 11, 2023. The analyst firm set a price target for 5.00 expecting TXMD to fall to within 12 months (a possible -3.66% downside). 5 analyst firms have reported ratings in the last year.
The stock price for TherapeuticsMD (NASDAQ: TXMD) is $5.19 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for TherapeuticsMD.
TherapeuticsMD’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for TherapeuticsMD.
TherapeuticsMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
TherapeuticsMD Stock (NASDAQ: TXMD) stock price, news, charts, stock research, profile.
Day Range5.080 - 5.270 | 52 Wk Range0.150 - 11.690 | Open / Close5.110 / 5.190 | Float / Outstanding9.384M / 9.467M |
Vol / Avg.17.368K / 137.924K | Mkt Cap49.134M | P/E- | 50d Avg. Price5.580 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float9.384M | EPS-0.960 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.570 | -2.750 | -2.1800 | ||||
REV | 26.800M | 20.917M | -5.883M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.
Other companies in TherapeuticsMD’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Lipocine (NASDAQ:LPCN) and Hepion Pharmaceuticals (NASDAQ:HEPA).
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on Wednesday, January 11, 2023. The analyst firm set a price target for 5.00 expecting TXMD to fall to within 12 months (a possible -3.66% downside). 5 analyst firms have reported ratings in the last year.
The stock price for TherapeuticsMD (NASDAQ: TXMD) is $5.19 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for TherapeuticsMD.
TherapeuticsMD’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for TherapeuticsMD.
TherapeuticsMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
TherapeuticsMD Stock (NASDAQ: TXMD) stock price, news, charts, stock research, profile.
Day Range5.080 - 5.270 | 52 Wk Range0.150 - 11.690 | Open / Close5.110 / 5.190 | Float / Outstanding9.384M / 9.467M |
Vol / Avg.17.368K / 137.924K | Mkt Cap49.134M | P/E- | 50d Avg. Price5.580 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float9.384M | EPS-0.960 |
Q4 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-03-09 | ||||||
REV |
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.570 | -2.750 | -2.1800 | ||||
REV | 26.800M | 20.917M | -5.883M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of TherapeuticsMD (NASDAQ: TXMD) through any online brokerage.
Other companies in TherapeuticsMD’s space includes: Cumberland (NASDAQ:CPIX), SCYNEXIS (NASDAQ:SCYX), Ocuphire Pharma (NASDAQ:OCUP), Lipocine (NASDAQ:LPCN) and Hepion Pharmaceuticals (NASDAQ:HEPA).
The latest price target for TherapeuticsMD (NASDAQ: TXMD) was reported by Cantor Fitzgerald on Wednesday, January 11, 2023. The analyst firm set a price target for 5.00 expecting TXMD to fall to within 12 months (a possible -3.66% downside). 5 analyst firms have reported ratings in the last year.
The stock price for TherapeuticsMD (NASDAQ: TXMD) is $5.19 last updated February 8, 2023 at 9:00 PM UTC.
There are no upcoming dividends for TherapeuticsMD.
TherapeuticsMD’s Q4 earnings are confirmed for Thursday, March 9, 2023.
There is no upcoming split for TherapeuticsMD.
TherapeuticsMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.